BioAmber, Reverdia settle non-assert agreement on Biosuccinium technology

Reverdia, the joint venture between Royal DSM and Roquette Frères, has signed a non-assert agreement with Canada-based sustainable chemicals firm, BioAmber, concerning the Biosuccinium technology, which Reverdia produces. Both firms are involved in the production and commercialisation of bio-based succinic acid using their own unique proprietary yeast-based technologies.

With the agreement, BioAmber will benefit from non-assertion covenants with respect to certain intellectual property rights of Reverdia in the field of bio-based succinic acid, in exchange for undisclosed financial consideration. Furthermore, the agreement provides comfort to both BioAmber and Reverdia to continue the implementation of their respective businesses using their own unique, proprietary yeast-based technologies.

Marcel Lubben, Reverdia’s President said that the yeast-based technologies have a significant competitive advantage over bacterial-based technologies for the production of bio-based succinic acid.

Meanwhile, JF Huc, BioAmber’s CEO commented that this agreement shows how “two proactive companies operating in the same field can find a constructive solution that allows them to focus on the execution of their respective business plans rather than seeking confrontation and conflict.”

Both Lubben and Hucagree that the market for succinic acid will benefit from having strong players able to deliver on the rapidly growing demand in bio-plastics, polyurethanes, solvents, coatings and other applications.